Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
11.97
-1.30 (-9.80%)
At close: Jun 5, 2026, 4:00 PM EDT
11.83
-0.14 (-1.20%)
After-hours: Jun 5, 2026, 7:55 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $3.72 billion as of June 5, 2026. Its market cap has increased by 977.07% in one year.
Market Cap
3.72B
Enterprise Value
3.36B
1-Year Change
977.07%
Ranking
Category
Stock Price
$11.97
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $3.72B, an increase of 100.32%. That is a compound annual growth rate of 15.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 3.72B | 252.71% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celcuity | 4.31B |
| Travere Therapeutics | 4.26B |
| Veradermics | 3.83B |
| Edgewise Therapeutics | 3.83B |
| Catalyst Pharmaceuticals | 3.83B |
| ACADIA Pharmaceuticals | 3.69B |
| NewAmsterdam Pharma Company | 3.68B |
| Oruka Therapeutics | 3.63B |